Home > Cancer > Cologuard receives FDA approval Get the Flash Player to see this player. Rate: (Click the stars to rate) Published on Aug 12, 2014 by MultiVu, Views: 2708 Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test.